-
Strategic PlanningStrategic Planning
Be a credible threat. As you seek funding, we create product development plans that align clinical and regulatory milestones with costs.
Development Strategy Used for Fundraising
Small virtual biotech start-up with stem-cell therapy treatment for HIV. Strong scientific expertise but limited experience in moving research phase work into early clinical (pre-IND) development.- Read more about Development Strategy Used for Fundraising
- Log in to post comments
-
Due DiligenceDue Diligence
Know what you’re up against. We inform decision making on product acquisition strategies by identifying both regulatory and operational risks.
Indication Selection
A Life sciences venture capital firm come to Halloran looking for help prioritizing potential indications for their lead oncology compound.- Read more about Indication Selection
- Log in to post comments
-
Road MappingRoad Mapping
What is possible, and what is probable. We bring together KOL opinions, market assessments, and reality, so you can make the business decisions.
Starting up a Life Science Division
A mature, global animal health company wanted to expand into human healthcare. The company was unsure whether their lead product was ready to advance to IND-enabling activities. The company also lacked expertise in human clinical product development.- Read more about Starting up a Life Science Division
- Log in to post comments
Meet the Plan team leads
Greg Dombal
Lyn Agostinelli, RN, BSN
Jason Milovanovic
Kim Raymer
Keri Urwin, MBA